The WACC of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is 9.5%.
| Range | Selected | |
| Cost of equity | 12.10% - 16.00% | 14.05% |
| Tax rate | 0.10% - 0.30% | 0.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 8.6% - 10.5% | 9.5% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.8 | 1.99 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 12.10% | 16.00% |
| Tax rate | 0.10% | 0.30% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 8.6% | 10.5% |
| Selected WACC | 9.5% | |